New applications for MRD measurement in myeloma: MRD 'over time'
Starving CLL cells of oxygen results in a new predictive test
Multiple myeloma highlights at ASH 2017
Venetoclax combination therapy for relapsed CLL
Identifying patients at different risk of relapse in childhood acute lymphoblastic leukemia (ALL)